Ultragenyx Pharmaceutical | 4: Statement of changes in beneficial ownership of securities-Officer Crombez Eric
Ultragenyx Pharmaceutical | 10-Q: Quarterly report
Ultragenyx Pharmaceutical | 8-K: Ultragenyx Reports First Quarter 2024 Financial Results and Corporate Update
Ultragenyx Pharmaceutical | DEFA14A: Others
Ultragenyx Pharmaceutical | ARS: Annual Report to Security Holders
Ultragenyx Pharmaceutical | DEF 14A: Definitive information statements
Ultragenyx Pharmaceutical | 4: Statement of changes in beneficial ownership of securities-Officer Crombez Eric
Ultragenyx Pharmaceutical | 4: Statement of changes in beneficial ownership of securities-Officer Huizenga Theodore Alan
Ultragenyx Pharmaceutical | 8-K: Current report
Ultragenyx Pharmaceutical | 4: Statement of changes in beneficial ownership of securities-Officer Kassberg Thomas Richard
Ultragenyx Pharmaceutical | 144: Notice of proposed sale of securities pursuant to Rule 144
Ultragenyx Pharmaceutical | 4: Statement of changes in beneficial ownership of securities-Director Fust Matthew K
Ultragenyx Pharmaceutical | 144: Notice of proposed sale of securities pursuant to Rule 144
Ultragenyx Pharmaceutical | 4: Statement of changes in beneficial ownership of securities-Officer Horn Howard
Ultragenyx Pharmaceutical | 4: Statement of changes in beneficial ownership of securities-Officer Parschauer Karah Herdman
Ultragenyx Pharmaceutical | 4: Statement of changes in beneficial ownership of securities-Officer Kassberg Thomas Richard
Ultragenyx Pharmaceutical | 4: Statement of changes in beneficial ownership of securities-Officer Pinion John Richard
Ultragenyx Pharmaceutical | 4: Statement of changes in beneficial ownership of securities-Officer Huang Dennis Karl
Ultragenyx Pharmaceutical | 4: Statement of changes in beneficial ownership of securities-Officer Huizenga Theodore Alan
Ultragenyx Pharmaceutical | 4: Statement of changes in beneficial ownership of securities-Officer Crombez Eric
No Data